Vepdegestrant Patent Expiration

Vepdegestrant was first introduced by Arvinas Operations Inc in its drug Veppanu on May 1, 2026.

Vepdegestrant Patents

Given below is the list of patents protecting Vepdegestrant, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

^NEW

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Veppanu	US10647698	Tetrahydronaphthalene And Tetrahydroisoquinoline Derivatives As Estrogen Receptor Degraders	Jan 30, 2038	Arvinas Operations
Veppanu	US10899742		Dec 01, 2037	Arvinas Operations
Veppanu	US11597720	Tetrahydronaphthalene And Tetrahydroisoquinoline Derivatives As Estrogen Receptor Degraders	Dec 01, 2037	Arvinas Operations

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List